Nicotinamide Mononucleotide, an NAD+ Precursor, Rescues Age-Associated Susceptibility to AKI in a Sirtuin 1–Dependent Manner
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
The rapid growth of an aging population creates challenges regarding age-related diseases, including AKI, for which both the prevalence and death rate increase with age. The molecular mechanism by which the aged kidney becomes more susceptible to acute injury has not been completely elucidated. In this study, we found that, compared with the kidneys of 3-month-old mice, the kidneys of 20-month-old mice expressed reduced levels of the renal protective molecule sirtuin 1 (SIRT1) and its cofactor NAD + . Supplementation with nicotinamide mononucleotide (NMN), an NAD + precursor, restored renal SIRT1 activity and NAD + content in 20-month-old mice and further increased both in 3-month-old mice. Moreover, supplementation with NMN significantly protected mice in both age groups from cisplatin-induced AKI. SIRT1 deficiency blunted the protective effect of NMN, and microarray data revealed that c-Jun N-terminal kinase (JNK) signaling activation associated with renal injury in SIRT1 heterozygotes. In vitro , SIRT1 attenuated the stress response by modulating the JNK signaling pathway, probably via the deacetylation of a JNK phosphatase, DUSP16. Taken together, our findings reveal SIRT1 as a crucial mediator in the renal aging process. Furthermore, manipulation of SIRT1 activity by NMN seems to be a potential pharmaceutical intervention for AKI that could contribute to the precise treatment of aged patients with AKI.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, they have demonstrated beneficial pharmacological activities in acute renal failure [28], anti-inflammatory [29–31], cardio and vasoprotective actions [32–35], telomere lengthening [36, 37•], extend lifespan and promote health in various organisms, from yeasts to mammals [10, 14, 15, 38].”
From NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health (2023) · cites this paper as [28]
In the citing paper
“NMN enhances mitochondrial function in various organs, including skeletal muscle201, kidney202–204, liver203, heart205, eyes206, brain161 and the cardiovascular system207, and can mitigate oxidative stress in the vasculature208, including improvements in neurovascular coupling responses in the aged cortex of the brain209.”
From NAD+ metabolism and its roles in cellular processes during ageing (2021) · cites this paper as [204]
Citations
Cites
Resveratrol improves health and survival of mice on a high-calorie diet
Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., Prabhu, V. V., Allard, J. S., Lopez-Lluch, G., Lewis, K., et al. (2006) · Nature · doi:10.1038/nature05354 · Cited by 4,290
Kaeberlein, M., McVey, M., & Guarente, L. (1999) · Genes & Development · doi:10.1101/gad.13.19.2570 · Cited by 2,253
Stereological Methods. Practical methods for biological morphometry
Weibel, E. R. (1979) · Academic Press eBooks · Cited by 1,994
Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes
Milne, J. C., Lambert, P. D., Schenk, S., Carney, D. P., Smith, J. J., Gagne, D. J., Jin, L., Boss, O., Perni, R. B., Vu, C. B., et al. (2007) · Nature · doi:10.1038/nature06261 · Cited by 1,707
Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans
Tissenbaum, H. A., & Guarente, L. (2001) · Nature · doi:10.1038/35065638 · Cited by 1,603
Practical methods for biological morphometry
Weibel, E. R. (1979) · Academic Press eBooks · Cited by 1,563
Gomes, A. P., Price, N. L., Ling, A. J. Y., Moslehi, J. J., Montgomery, M. K., Rajman, L., White, J. P., Teodoro, J. S., Wrann, C. D., Hubbard, B. P., et al. (2013) · Cell · doi:10.1016/j.cell.2013.11.037 · Cited by 1,482
NAD+ and sirtuins in aging and disease
Imai, S.-I., & Guarente, L. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.04.002 · Cited by 1,481
Sir2 mediates longevity in the fly through a pathway related to calorie restriction
Rogina, B., & Helfand, S. L. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404184101 · Cited by 1,361
Yoshino, J., Mills, K. F., Yoon, M. J., & Imai, S.-I. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.08.014 · Cited by 1,340
Cited by
Items 101–200 of 238
Ramanathan, C., Lackie, T., Williams, D. H., Simone, P. S., Zhang, Y., & Bloomer, R. J. (2022) · Nutrients · doi:10.3390/nu14020300 · Cited by 35
Yao, L., Wu, Y., Zhuang, W., Zhao, H., Nie, W., Wu, G., Pang, D., & Xie, H.-Y. (2025) · Nature Biomedical Engineering · doi:10.1038/s41551-025-01402-y · Cited by 42
Impaired Nicotinamide Adenine Dinucleotide Biosynthesis in the Kidney of Chronic Kidney Disease
Liu, X., Luo, D., Huang, S., Liu, S., Zhang, B., Wang, F., Lu, J., Chen, J., & Li, S. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.723690 · Cited by 35
NAD + Precursors in Human Health and Disease: Current Status and Future Prospects
Yaku, K., & Nakagawa, T. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2023.0354 · Cited by 33
Epigenetic Regulation in Kidney Toxicity: Insights From Cisplatin Nephrotoxicity
Xiang, X., Guo, C., Tang, C., Cai, J., & Dong, Z. (2019) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2018.12.005 · Cited by 36
Xing, S., Hu, Y., Huang, X., Shen, D., & Chen, C. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10782 · Cited by 41
Self-citationZhen, X., Zhang, S.-W., Xie, F., Zhou, M., Hu, Z., Zhu, F., & Nie, J. (2021) · Kidney Diseases · doi:10.1159/000510943 · Cited by 31
NAD+ supplementation limits triple-negative breast cancer metastasis via SIRT1-P66Shc signaling
Jiang, Y., Luo, Z., Gong, Y., Fu, Y., & Luo, Y. (2023) · Oncogene · doi:10.1038/s41388-023-02592-y · Cited by 30
Sonavane, M., Hayat, F., Makarov, M. V., Migaud, M. E., & Gassman, N. R. (2020) · PLoS ONE · doi:10.1371/journal.pone.0242174 · Cited by 30
NAD+ Homeostasis in Diabetic Kidney Disease
Xu, J., Kitada, M., & Koya, D. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.703076 · Cited by 33
Chen, C.-C., Chang, Z., Tsai, F., & Chen, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186766 · Cited by 32
Organ Protection by Caloric Restriction Depends on Activation of the De Novo NAD+ Synthesis Pathway
Späth, M. R., Hoyer-Allo, K. J. R., Seufert, L., Höhne, M., Lucas, C., Bock, T., Isermann, L., Brodesser, S., Lackmann, J., Kiefer, K., et al. (2023) · Journal of the American Society of Nephrology · doi:10.1681/asn.0000000000000087 · Cited by 27
Role of SIRT1 in HIV-associated kidney disease
Wang, X., Liu, R., Zhang, W., Hyink, D. P., Das, G. C., Das, B. C., Li, Z., Wang, A. A., Yuan, W., Klotman, P. E., et al. (2020) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00140.2020 · Cited by 29
Nicotinamide and acute kidney injury
Fontecha‐Barriuso, M., López-Diaz, A. M., Carriazo, S. M., Ortíz, A., & Sanz, A. B. (2021) · Clinical Kidney Journal · doi:10.1093/ckj/sfab173 · Cited by 28
Nanosystems for oxidative stress regulation in the anti-inflammatory therapy of acute kidney injury
Wang, Y., Jiang, H., Zhang, L., Yao, P., Wang, S., & Yang, Q. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1120148 · Cited by 35
Self-citationSun, Z., Liu, L., Liang, H., & Zhang, L. (2024) · Molecular Carcinogenesis · doi:10.1002/mc.23673 · Cited by 28
Al-Gayyar, M. M. H., Bagalagel, A. A., Noor, A. O., Almasri, D. M., & Diri, R. M. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108653 · Cited by 28
Wu, W., Yuan, S., Tang, Y., Meng, X., Peng, M., Hu, Z., & Liu, W. (2023) · Nutrients · doi:10.3390/nu15132851 · Cited by 30
Advances in the Synthesis and Physiological Metabolic Regulation of Nicotinamide Mononucleotide
Zheng, C., Li, Y., Wu, X., Gao, L., & Chen, X. (2024) · Nutrients · doi:10.3390/nu16142354 · Cited by 28
Advancements in NMN biotherapy and research updates in the field of digestive system diseases
Liao, G., Xie, Y., Peng, H., Li, T., Zou, X., Yue, F., Guo, J., & Rong, L. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05614-9 · Cited by 30
Raji-Amirhasani, A., Khaksari, M., Mahani, F. D., & Hajializadeh, Z. (2021) · Clinical and Experimental Nephrology · doi:10.1007/s10157-021-02057-0 · Cited by 26
NAD+ Metabolism and Interventions in Premature Renal Aging and Chronic Kidney Disease
Chanvillard, L., Tammaro, A., & Sorrentino, V. (2022) · Cells · doi:10.3390/cells12010021 · Cited by 29
Song, X., Cao, W., Wang, Z., Li, F., Xiao, J., Zeng, Q., Wang, Y., Li, S., Ye, C., Wang, Y., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232416085 · Cited by 28
Wang, Y., Yang, J.-S., Zhao, M., Chen, J., Xie, H.-X., Yu, H., Liu, N.-H., Yi, Z.-J., Liang, H., Xing, L., et al. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115355 · Cited by 27
Benjamin, C., & Crews, R. (2024) · Metabolites · doi:10.3390/metabo14060341 · Cited by 26
Iskander, A., & Yan, L. (2022) · Biomolecules · doi:10.3390/biom12081078 · Cited by 29
Hill, L. J., & Williams, A. C. (2017) · International Journal of Tryptophan Research · doi:10.1177/1178646917704662 · Cited by 28
NAD+ metabolism in acute kidney injury and chronic kidney disease transition
Alhumaidi, R., Huang, H., Saadé, M. C., Clark, A. J., & Parikh, S. M. (2025) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2024.12.004 · Cited by 25
Circular RNA expression profiles in cisplatin-induced acute kidney injury in mice
Li, C., Li, M., Ye, Z., Huang, J., Li, Y., Yao, Z., Peng, H., & Lou, T. (2019) · Epigenomics · doi:10.2217/epi-2018-0167 · Cited by 22
Pathobiochemistry of Aging and Neurodegeneration: Deregulation of NAD+ Metabolism in Brain Cells
Kolotyeva, N. A., Groshkov, A. A., Rozanova, N. A., Berdnikov, A. K., Novikova, S. V., Komleva, Y. K., Salmina, A. B., Illarioshkin, S. N., & Пирадов, М. А. (2024) · Biomolecules · doi:10.3390/biom14121556 · Cited by 24
Outcome of acute kidney injury: how to make a difference?
Jamme, M., Legrand, M. M., & Géri, G. (2021) · Annals of Intensive Care · doi:10.1186/s13613-021-00849-x · Cited by 23
The Significance of NAD+ Biosynthesis Alterations in Acute Kidney Injury
Clark, A. J., Saadé, M. C., & Parikh, S. M. (2022) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2022.10.013 · Cited by 18
NAM protects against cisplatin-induced acute kidney injury by suppressing the PARP1/p53 pathway
Wu, W., Fu, Y., Liu, Z., Shu, S., Wang, Y., Tang, C., Cai, J., & Dong, Z. (2021) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2021.115492 · Cited by 21
New drugs for acute kidney injury
Hariri, G., & Legrand, M. M. (2024) · Journal of Intensive Medicine · doi:10.1016/j.jointm.2024.08.001 · Cited by 27
Ma, D., Hu, L., Wang, J., Luo, M., Liang, A., Lei, X., Liao, B., Li, M., Ming, X., Li, H., et al. (2022) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2022099 · Cited by 23
Safety Evaluation for Restorin® NMN, a NAD+ Precursor
Turner, J. R., Licollari, A., Mihalcea, E., & Tan, A. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.749727 · Cited by 19
Technology and functional insights into the nicotinamide mononucleotide for human health
Liu, Y., Gong, J., Marshall, G., Su, C., Shi, J., & Xu, Z. (2023) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-023-12612-2 · Cited by 19
Parikh, S. M. (2019) · The Nephron journals/Nephron journals · doi:10.1159/000500168 · Cited by 18
The role of SIRT1 in kidney diseases
Wang, W. J., Hu, Y., Ding, N., Wei, J., & Li, C. (2024) · International Urology and Nephrology · doi:10.1007/s11255-024-04162-x · Cited by 17
Chini, C. C. S., Peclat, T., Gomez, L. S., Zeidler, J. D., Warner, G. M., Kashyap, S., Mazdeh, D. Z., Hayat, F., Migaud, M. E., Paulus, A., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.840246 · Cited by 19
Hasegawa, K., Sakamaki, Y., Tamaki, M., & Wakino, S. (2022) · Scientific Reports · doi:10.1038/s41598-022-18147-2 · Cited by 19
Tao, Y., Wang, J., Lyu, X., Li, N., Lai, D., Liu, Y., Zhang, X., Li, P., Cao, S., Zhou, X., et al. (2023) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2023.100510 · Cited by 17
Liu, H., Cheng, H., Wang, H., Wang, Q., & Yuan, J. (2023) · Renal Failure · doi:10.1080/0886022x.2023.2253924 · Cited by 17
Zhang, H., Chai, J., Cao, C., Wang, X., & Pang, W. (2024) · Antioxidants · doi:10.3390/antiox13050507 · Cited by 19
Margier, M., Kuehnemann, C., Hulo, N., Morales, J. E., Kumaar, P. V. A., Cros, C. D., Cannelle, H., Charmetant, J., Verdin, E. M., Canault, M., et al. (2022) · Cells · doi:10.3390/cells12010108 · Cited by 18
The metabolites ofde novoNAD+ synthesis are a valuable predictor of acute kidney injury
Wang, Y., Guan, Y., Xie, Q., Gong, W., Li, J., Chen, T., Xu, Y., Xu, N., Chen, S., Chen, M., et al. (2022) · Clinical Kidney Journal · doi:10.1093/ckj/sfac262 · Cited by 20
Self-citationAntioxidant effect of nicotinamide mononucleotide in tendinopathy
Yamaura, K., Mifune, Y., Inui, A., Nishimoto, H., Kurosawa, T., Mukohara, S., Hoshino, Y. Y., Niikura, T., & Kuroda, R. (2022) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-022-05205-z · Cited by 20
Bai, L., Yau, L., Tong, T., Chan, W.-H., Zhang, W., & Jiang, Z. (2022) · Pharmacology Research & Perspectives · doi:10.1002/prp2.986 · Cited by 14
Synthesis of β‐Nicotinamide Riboside Using an Efficient Two‐Step Methodology
Zhang, N., & Sauve, A. A. (2017) · Current Protocols in Nucleic Acid Chemistry · doi:10.1002/cpnc.43 · Cited by 16
State of the art – sirtuin 1 in kidney pathology – clinical relevance
Bielach-Bazyluk, A., Małyszko, J., Hryszko, T., & Zbroch, E. (2019) · Advances in Medical Sciences · doi:10.1016/j.advms.2019.04.005 · Cited by 17
Bufalin alleviates acute kidney injury by regulating NLRP3 inflammasome-mediated pyroptosis
Ding, L., Yin, J., Xu, X., Xie, D., Xiang, D., Tong, P., Liu, S., & Yang, X. (2023) · APOPTOSIS · doi:10.1007/s10495-023-01815-7 · Cited by 17
Podocyte Metabolic Reprogramming and Targeted Therapy
Hu, H., Liang, W., & Ding, G. (2025) · Journal of the American Society of Nephrology · doi:10.1681/asn.0000000917 · Cited by 14
Hu, J., Hou, W., Ma, N., Zhang, Y., Liu, X., Wang, Y., & Ci, X. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122352 · Cited by 15
The tryptophan pathway and nicotinamide supplementation in ischaemic acute kidney injury
Piedrafita, A., Balayssac, S., Mayeur, N., Gazut, S., Grossac, J., Buléon, M., Alvès, M., Klein, J., Minville, V., Marcheix, B., et al. (2021) · Clinical Kidney Journal · doi:10.1093/ckj/sfab050 · Cited by 16
Guimera, A. M., Clark, P. A., Wordsworth, J., Anugula, S., Rasmussen, L. J., & Shanley, D. P. (2022) · Experimental Gerontology · doi:10.1016/j.exger.2022.111889 · Cited by 13
Fertility protection during chemotherapy treatment by boosting the NAD(P)+ metabolome
Ho, W.-H. J., Marinova, M. B., Listijono, D. R., Bertoldo, M. J., Richani, D., Kim, L., Brown, A., Riepsamen, A. H., Cabot, S., Frost, E. R., et al. (2024) · EMBO Molecular Medicine · doi:10.1038/s44321-024-00119-w · Cited by 15
Advances in pharmacotherapy for acute kidney injury
Xu, Y., Zou, P., & Cao, X. (2022) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2022.2050214 · Cited by 13
Self-citationWang, Y., Shen, Z., Mo, S., Zhang, H., Chen, J., Zhu, C. G., Lv, S., Zhang, D., Huang, X., Gu, Y., et al. (2024) · Human Cell · doi:10.1007/s13577-024-01072-z · Cited by 15
Self-citationHe, Y., Lipa, K. E., Alexander, P. G., Clark, K. L., & Lin, H. (2022) · Biology · doi:10.3390/biology11070996 · Cited by 16
Imi, Y., Amano, R., Kasahara, N., Obana, Y., & Hosooka, T. (2023) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2023.101476 · Cited by 16
Histone Deacetylases Take Center Stage on Regulation of Podocyte Function
Liu, M., Qiao, Z., Zhang, Y., Zhan, P., & Yi, F. (2020) · Kidney Diseases · doi:10.1159/000507117 · Cited by 12
NAD+ metabolism and retinal degeneration (Review)
Pîrvu, A. S., Andrei, A. M., Stănciulescu, E. C., Baniţă, I. M., Pisoschi, C. G., Jurja, S., & Ciuluvica, R. C. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10102 · Cited by 13
Calorie restriction mimetics against aging and inflammation
Chaudhary, S., Chaudhary, M. R., Jena, M. K., Rath, P. K., Mishra, B. P., Paital, B., Vyas, A., Sahoo, D. K., Singh, P., & Mehdi, M. M. (2025) · Biogerontology · doi:10.1007/s10522-025-10269-0 · Cited by 15
Hypoxia-Driven Responses in Chronic Kidney Disease
Miguel, V., & Rojo, A. (2023) · Oxygen · doi:10.3390/oxygen3030020 · Cited by 15
Song, M., Yin, C., Xu, Q., Liu, Y., Zhang, H., Liu, X., & Yan, H. (2023) · Foods · doi:10.3390/foods12152897 · Cited by 11
NMN does not protect the ovarian reserve from cancer treatments
Stringer, J. M., Groenewegen, E., Liew, S. H., & Hutt, K. J. (2020) · Reproduction · doi:10.1530/rep-19-0337 · Cited by 13
PPARγ-Coactivator-1α, Nicotinamide Adenine Dinucleotide and Renal Stress Resistance
Mehr, A. P., & Parikh, S. M. (2017) · The Nephron journals/Nephron journals · doi:10.1159/000471895 · Cited by 13
Tuncay, E., Gando, I., Huo, J., Yepuri, G., Samper, N., Turan, B., Yang, H.-Q., Ramasamy, R., & Coetzee, W. A. (2023) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00459.2022 · Cited by 10
Huangqi-Danshen decoction protects against cisplatin-induced acute kidney injury in mice
Liu, X., Gao, L., Huang, X., Deng, R., Wu, S., Peng, Y., & Lu, J. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1236820 · Cited by 11
Self-citationYang, S., Gong, W., Wang, Y., Hao, C., & Guan, Y. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1384953 · Cited by 12
Self-citationSirtuins in kidney homeostasis and disease: where are we now?
Fan, Z., Wei, X. S., Zhu, X., & Du, Y. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1524674 · Cited by 11
Innovations and Emerging Therapies to Combat Renal Cell Damage: NAD + As a Drug Target
Manrique‐Caballero, C. L., Kellum, J. A., Gómez, H., Franco, F., Giacchè, N., & Pellicciari, R. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8066 · Cited by 11
Prevention of Chronic Kidney Disease and Its Complications in Older Adults
Tungsanga, S., & Bello, A. K. (2024) · Drugs & Aging · doi:10.1007/s40266-024-01128-7 · Cited by 10
Use of Nicotinamide Mononucleotide as Non-Natural Cofactor
Naaz, T., & Kim, B. S. (2025) · Catalysts · doi:10.3390/catal15010037 · Cited by 10
Mou, H.-C., Zhang, X., Ren, F., Deng, Y., Chi, A., Zhan, G., Li, D., Sun, Q., You, W., Ge, Y., et al. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114407 · Cited by 9
Ren, Z., Shao, F., Chen, S., Sun, Y., Ding, Z., Dong, L., Zhang, J., & Zang, Y. (2025) · The Journal of Pathology · doi:10.1002/path.6414 · Cited by 11
Zhou, Q., Li, J., Xiang, Z., Zou, H., & Shao, X. (2022) · BioMed Research International · doi:10.1155/2022/7140961 · Cited by 9
Nishimura, E. S., Hishikawa, A., Nakamichi, R., Akashio, R., Chikuma, S., Hashiguchi, A., Yoshimoto, N., Hama, E. Y., Maruki, T., Ito, W., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-59297-x · Cited by 14
Recent Advances in the Chemical Synthesis of β-Nicotinamide Mononucleotide
Ming, W., Hu, S., Liu, Y., Li, Q.-A.-W., Zhu, Y., & Gu, S.-X. (2023) · Current Organic Chemistry · doi:10.2174/1385272827666230201103848 · Cited by 9
Miao, C., Zheng, S., Wang, D., Dong, X. W., Guan, Y., Qi, Q., Hu, W., Hong, C., & Zhang, C. (2022) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201023666220518113219 · Cited by 9
Self-citationTubular insulin-induced gene 1 deficiency promotes NAD+ consumption and exacerbates kidney fibrosis
Li, S., Qin, J., Zhao, Y., Wang, J., Huang, S., & Yu, X. (2024) · EMBO Molecular Medicine · doi:10.1038/s44321-024-00081-7 · Cited by 6
NAD+ enhancers as therapeutic agents in the cardiorenal axis
Marin-Blazquez, M., Rovira, J., Ramírez-Bajo, M. J., Perez, R. Z., & Rabadán-Ros, R. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01903-4 · Cited by 7
PPDPF preserves integrity of proximal tubule by modulating NMNAT activity in chronic kidney diseases
Fang, X., Zhong, Y., Zheng, R., Wu, Q., Liu, Y., Zhang, D., Wang, Y., Ding, W., Wang, K., Zhong, F., et al. (2025) · Science Advances · doi:10.1126/sciadv.adr8648 · Cited by 7
Self-citationMarchiset, A., & Jamme, M. (2022) · Frontiers in Nephrology · doi:10.3389/fneph.2022.877529 · Cited by 11
Metabolite accumulation from oral NMN supplementation drives aging-specific kidney inflammationPreprint
Saleh, T. A., Whitson, J. D., Keiser, P., Prasad, P., Jenkins, B. C., Sodeinde, T., Mann, C. N., Rabinovitch, P. S., McReynolds, M. R., & Sweetwyne, M. T. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.09.588624 · Cited by 7
Zhang, C., Li, Y., Bai, F., Talifu, Z., Ke, H., Xu, X. P., Li, Z., Liu, W., Pan, Y., Gao, F., et al. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1323566 · Cited by 7
Lin, S.-Y., Syu, J.-P., Lo, Y., Chau, Y., Don, M., Shy, H.-T., Lai, S.-M., & Kung, H. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154094 · Cited by 4
Ulpathakumbura, S., Lu, S., Gunarathne, R., Yang, J. Z., Liu, J., Jin, X., Zhou, Q., & Lu, J. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102992 · Cited by 11
Comprehensive bibliometric analysis of sirtuins: Focus on sirt1 and kidney disease
Liu, T., Mu, S., Yang, L., Mao, H., Ma, F., Wang, Y., & Zhan, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.966786 · Cited by 4
Yu, J., Shen, Q., & Li, J. (2024) · Current Research in Toxicology · doi:10.1016/j.crtox.2024.100171 · Cited by 4
Vogelaar, Y., Mourisse, L., & Pickkers, P. (2025) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000001331 · Cited by 4
Natural products in regeneration
Wilson, R. B., Lee, J. J., Pickering, J. G., & Borradaile, N. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823318-4.00027-5 · Cited by 4
Yu, Z., Tong, S., Zhang, C., Bai, Y. Y., An, Z., Xu, C., Wang, F., Hu, Y., Zhuang, Q., & Zhong, X. (2022) · Research Square · doi:10.21203/rs.3.rs-1483519/v1 · Cited by 3
Herath, S., Au, A. Y. M., Taylor, K. M., Kapoor‐Kaushik, N., Endre, Z. H., & Erlich, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26104616 · Cited by 2
SIRT1 as a potential target for age-related eye diseases: mechanisms and therapeutic strategies
Liu, H., Ouyang, Y., & Ge, H. (2025) · Human Cell · doi:10.1007/s13577-025-01285-w · Cited by 2
Liu, S., Shi, P., Jin, Y., Fan, L., Ni, Q., Mao, J., Shao, Z., Du, X., Chen, H., & Fu, M. (2026) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2026.117709 · Cited by 2
Qin, W., Zhang, Z., Chen, X., Xu, W., Xu, Q., & Chen, C. (2026) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2025.127355 · Cited by 2
SIRT Family: Biological Functions and Therapeutic Targets
Wang, J., Jiang, F., ZHANG, F.-Y., Huang, D., Li, X. G., Gao, S., You, H., Wu, Q., Chen, H., & Gong, T. Q. (2026) · MedComm · doi:10.1002/mco2.70866 · Cited by 2
The structural Basis of NMN synthesis catalyzed by NadV from Haemophilus ducreyi
Wang, Z.-J., Jia, Y., & Tang, L. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.150889 · Cited by 2
NAD+ flux is maintained in aged micePreprint
McReynolds, M. R., Chellappa, K., Chiles, E. N., Jankowski, C. S. R., Shen, Y., Chen, L., Descamps, H. C., Mukherjee, S., Bhat, Y. R., Chu, Q., et al. (2020) · Research Square · doi:10.21203/rs.3.rs-86538/v1 · Cited by 2
Metadata
- Authors
- Guan, Y., Wang, S.-R., Huang, X.-Z., Xie, Q.-H., Xu, Y.-Y., Shang, D., & Hao, C.-M.
- Affiliations
- Fudan University (CN)
- Corresponding author
- Shang, Da
- Hao, Chuan-Ming
- Venue
- Journal of the American Society of Nephrology
- Published
- 2017-02-28
- Volume
- 28
- Issue
- 8
- Pages
- 2337-2352
- ISSN
- 1046-6673 (ISSN-L)
- 1533-3450
- PMC
- PMC5533221
- OpenAlex
- W2592892973
- Cited by
- 238
- References
- 53
- Citations by year
- 2026: 18 · 2025: 24 · 2024: 28 · 2023: 28 · 2022: 40 · 2021: 38 · 2020: 26 · 2019: 20 · 2018: 8 · 2017: 8
- FWCI
- 10.25
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Journal of the American Society of Nephrology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China
- Chinese Academy of Sciences
- Fudan University
- National Key Research and Development Program of China
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Chemotherapy-induced organ toxicity mitigation
- Keywords
- nicotinamide mononucleotide, NAD+ precursors, SIRT1, acute kidney injury, kidney aging, cisplatin nephrotoxicity, JNK signaling, DUSP16, NAD+ depletion, renal protection
- MeSH terms
- Age Factors, Animals, Disease Susceptibility, NAD, Nicotinamide Mononucleotide, JNK Mitogen-Activated Protein Kinases, Mice, Sirtuin 1, Acute Kidney Injury
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.